Vivek Das/LinkedIn
Jul 31, 2026, 07:54
Vivek Das: From Inflammation to Integrated Precision Cardiovascular Care
Vivek Das, Lead Data Scientist at Novo Nordisk, shared a post on LinkedIn:
“A timely review from the European Society of Cardiology highlights an important direction for precision cardiovascular medicine.
While inflammation remains a key driver of coronary artery disease, meaningful progress will increasingly depend on integrating biomarkers, imaging, multi-omics, and clinical evidence to better understand residual risk and support more individualized care.
Equally important, translating these advances into practice will require robust evidence, careful validation, and thoughtful implementation.
An insightful read for anyone interested in the future of biomarkers and precision medicine.”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders